Table 2.
Dakar, Senegal (14) (univ. hosp.) age* 1–10+ n = 556 |
Zaria, Nigeria (15) (univ. hosp.) age 10–52 n = 208 |
Ibadan, Nigeria (16) (univ. hosp.) age 3–16 n = 145 |
Ouagadougou, Burkina Faso (18) (urban hosp.) age 1–42 n = 387 |
Ouagadougou, Burkina Faso (17) (screening) age 1–30 n = 153 |
Greece National Registry (19) --- n = 1080 |
Riyadh, Saudi Arabia (38) (univ. hospital) age 1–69 n = 159 |
Andhra Pradesh, India (21) (screening) --- N = 78 |
Chennai, India (20) (urban hosp.) --- n = 22 |
|
---|---|---|---|---|---|---|---|---|---|
Hb SS | 95.7% | 95.2% | 87.6% | 50.4% | 7.8% | 19.0% | 71.7% | 67.9% | 36.4% |
Hb SC | 3.6% | 4.8% | 12.4% | 49.6% | 92.2% | --- | --- | --- | --- |
Hb Sβ-thal | 0.7% | --- | --- | --- | --- | 81.0% | 28.3%1 | 30.8% | 63.6% |
Hb SD | --- | --- | --- | --- | --- | --- | --- | 1.3% |
age given in years
26.4% Hb Sβ0-thalassemia; 0.2% Hb Sβ+-thalassemia